On September 30, the Centers for Disease Control and Prevention announced the first confirmed case of Ebola in the U.S. One bright spot, however, is that it put some companies in the spotlight. Investment U Explains how to build an Ebola-proof portfolio while Tom Sandford's article discusses the big movers in biotech.
The decline in oil price has prompted the re-pricing of energy equities, which dropped nearly 19% in the past month. Looking at momentum indicators, it is clear that this sector is oversold. When combined with the seasonal tendency for energy shares to rise in November, exploration and development companies could be a bargain.